tRF-1:28-Val-CAC-2 promotes the development of nasopharyngeal cancer by targeting EPHB2
These results demonstrate that tRF-1:28-Val-CAC-2 promoted <i>EPHB2</i> to enhance tumorigenic behavior in NPC cells, underscoring its key role as a novel target for therapeutic intervention.
Authors
- Yehai Liu (ORCID: https://orcid.org/0000-0003-3977-2481)
- Antonia RuJia Sun (ORCID: https://orcid.org/0000-0003-0108-9046)
- Kai Zhang (ORCID: https://orcid.org/0000-0001-6596-6728)
- Huijun Li (ORCID: https://orcid.org/0000-0002-2896-3867)
- Mingjie Zhang (ORCID: https://orcid.org/0000-0001-9404-0190)
- Weiwei Liu (ORCID: https://orcid.org/0000-0003-4708-8057)
- Shiyin Ma
- Ruipeng Lv (ORCID: https://orcid.org/0009-0000-0724-7629)
- Zhiwei Xing
- Xiaomin Wang
Institutions
- Anhui Medical University (CN)
- Anhui Science and Technology University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.3389/fonc.2025.1564601
- Citations
- 1
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Bengbu Medical College
- Anhui Provincial Department of Education